found that SCARA5 significantly inhibited gastric cancer cells, with an inhibitory effect of 69.4%, tumor proliferation index of 23.3%, apoptotic index of 47.3%, and reduced tumor angiogenesis (43). The gene discussed is SCARA5; the disease is neoplasm.